Evidence map›Paper›PMID 34850164›Full record

Trial reportNicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco2022

Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial.

Jonathan Foulds, Caroline O Cobb, Miao-Shan Yen, Susan Veldheer, Phoebe Brosnan, Jessica Yingst, Shari Hrabovsky, Alexa A Lopez, Sophia I Allen, Christopher Bullen and 11 more

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed, 10 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 10 syntheses or guidelines pooled it, 67 citations in OpenAlex.

  1. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2026
    Pooled it
  2. Pooled it
  3. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Recommendations on interventions for tobacco smoking cessation in adults in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  5. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2025
    Guideline
  6. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2025
    Pooled it
  7. Pooled it
  8. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2024
    Pooled it
  9. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2022
    Pooled it
  10. Electronic cigarettes for smoking cessation.The Cochrane database of systematic reviews · 2021
    Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Changes in Nicotine Dependence Among Smokers Using Electronic Cigarettes to Reduce Cigarette Smoking in a Randomized Controlled Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2023
    Trial
  19. Trial
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 4 institutions in 2 countries.

Jonathan FouldsCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.ORCID 0000-0003-2296-0726
Caroline O CobbCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, VA, USA.ORCID 0000-0003-3258-252X
Miao-Shan YenCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, VA, USA.
Susan VeldheerCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.
Phoebe BrosnanCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, VA, USA.
Jessica YingstCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.
Shari HrabovskyCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.
Alexa A LopezCollege of Nursing, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
Sophia I AllenCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.ORCID 0000-0002-1809-3749
Christopher BullenSchool of Population Health, University of Auckland, Auckland, New Zealand.ORCID 0000-0001-6807-2930
Xi WangCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.
Chris SciamannaCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.
Erin HammettCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.
Breianna L HummerCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.
Courtney LesterCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.
John P RichieCenter for Research on Tobacco & Health, Penn State College of Medicine, Hershey, PA, USA.
Nadia ChowdhuryCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, VA, USA.
Jacob T GrahamCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, VA, USA.
Le KangCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, VA, USA.
Shumei SunCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, VA, USA.
Thomas EissenbergCenter for the Study of Tobacco Products, Virginia Commonwealth University, Richmond, VA, USA.
Penn State Milton S. Hershey Medical Center · USVirginia Commonwealth University · USUniversity of Auckland · NZUniversity of Wisconsin–Milwaukee · US

Funding

Penn State Clinical and Translational Science InstituteUL1TR002014 · NCATS · PENNSYLVANIA STATE UNIV HERSHEY MED CTR · PI KRASCHNEWSKI, JENNIFER L. · 2016 to 2025
$33.7M
Project 4: Using a prospective cohort survey to test population-level predictions generated by Projects 1-3U54DA036105 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI FAGAN, PEBBLES · 2018 to 2022
$20.8M
Training and Education Core p270-287P50DA036105 · NIDA · VIRGINIA COMMONWEALTH UNIVERSITY · PI EISSENBERG, THOMAS EVAN · 2013 to 2017
$19.2M
Research Supplement to Promote Diversity in Health Related ResearchUL1TR002649 · NCATS · VIRGINIA COMMONWEALTH UNIVERSITY · PI MOELLER, FREDERICK GERARD · 2018 to 2022
$19.1M
NCATS NIH HHS UL1 TR002014NCATS NIH HHS UL1 TR002649NIDA NIH HHS P50 DA036105NIDA NIH HHS U54 DA036105
6 · The paper itself

Abstract

introductionThe extent to which use of electronic nicotine delivery systems (ENDS) for smoking reduction leads to cigarette abstinence in smokers with no plans to quit smoking is unclear. This exploratory analysis examined the effects of ENDS delivering different amounts of nicotine on cigarette abstinence up to 24-week follow-up, in comparison to placebo or a behavioral substitute.

methodsThis four-arm parallel-group, randomized, placebo-controlled trial took place at two academic medical centers in the United States (Penn State Hershey and Virginia Commonwealth University). Participants were current adult smokers (N = 520) interested in reducing but not planning to quit. They received brief advice and were randomized to one of four 24-week conditions, receiving either an eGo-style ENDS paired with 0, 8, or 36 mg/ml nicotine liquid (double-blind) or a cigarette-shaped tube, as a cigarette substitute (CS). Self-reported daily cigarette consumption and exhaled carbon monoxide (CO) were measured at all study visits. Outcomes included intent-to-treat, self-reported 7-day cigarette abstinence, biochemically confirmed by exhaled CO at 24 weeks after randomization.

resultsAt 24 weeks, significantly more participants in the 36 mg/ml condition (14/130, 10.8%) than in the 0 mg/ml condition (1/130, 0.8%) and the CS condition (4/130, 3.1%) were abstinent (relative risk = 14 [95% CI = 1.9-104.9] and 3.5 [95% CI = 1.2-10.4], respectively). The abstinence rate in the 8 mg/ml condition was 4.6% (6/130).

conclusionsWhen smokers seeking to reduce smoking tried ENDS, few quit smoking in the short term. However, if smokers continued to use an ENDS with cigarette-like nicotine delivery, a greater proportion completely switched to ENDS, as compared with placebo or a cigarette substitute. IMPLICATIONS: The extent to which use of electronic nicotine delivery systems (ENDS) for smoking reduction leads to cigarette abstinence in smokers with no plans to quit smoking was unclear. This randomized trial found that ENDS with nicotine delivery approaching that of a cigarette are more effective in helping ambivalent smokers to quit cigarette smoking.

Indexed as

Electronic Nicotine Delivery SystemsSmoking CessationTobacco ProductsAdultHumansNicotineSmokersUnited StatesNicotine

Identifiers

PMID34850164
PMCPMC9391685
OpenAlexW3217481211

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.